Milind Parate Chief Financial Officer & Investor Relations Milind joins MEMOTEXT with more than 16 years on Wall Street where he covered the healthcare sector across investment banking (M&A,
Health care systems face ever-growing challenges: widening inequalities, emerging infectious and environmental risks, the rise of noncommunicable diseases (NCDs), and ageing populations. Universal health coverage (UHC) is a goal “to
MEMOTEXT, a company specializing in developing and delivering personalized digital health interventions, today announced a collaboration with Massachusetts General Hospital (MGH) to create a text-messaging-based program that can help address
There is much talk about the need to embrace digital health solutions as one of the key strategies needed to successfully compete in a transformed value-driven healthcare delivery environment but
Optimal Birth BC, a partnership between academic researchers from UBC and provincial health authorities, have launched a research program to examine the effectiveness and scalability of a prenatal education program
Co-written by Amos Adler (MEMOTEXT) and Donna Hui (ARIAD HEALTH/BLUESPIRE), February 6, 2017 First there was Eliza. Developed in the 60s, Eliza was a psychotherapist bot that would recognize keywords
Allergan Inc. has partnered with STI Technologies Limited and MEMOTEXT to launch the Restasis® treatment support pilot program: a digital health patient adherence and support program aimed at improving medication
Ohio State University and MEMOTEXT Corporation have collaborated on a number of different research studies together. Lisa Militello, a post-doctoral researcher is a firm believer that the dynamic simplicity of
I’ve now recovered from my #MedXhangover. The term commonly used to refer to the general malaise that the majority of attendees experience once they return to real-life after spending three
The HIV Prevention Trials Network (HPTN) has launched a research study examining the feasibility and scalability of an integrated, enhanced, case manager care strategy to attain and maintain viral suppression
MEMOTEXT is returning to Stanford MedX! On Sunday September 18 @ 11:00AM come and visit us in the lower lobby. We will be presenting our poster entitled: Using personalized digital
CAMH and MEMOTEXT sign MOU to co-develop mobile health intervention for schizophrenia (TORONTO) May 11, 2016 – The Centre for Addiction and Mental Health (CAMH) and MEMOTEXT Corporation have signed
We use cookies to ensure you get the best experience on our website. By continuing to browse this website, you accept the use of the cookies for the stated purpose. Learn more by reading our privacy policy.
Get updates on new products, projects and stay on top of all things MEMOTEXT.